Detalhe da pesquisa
1.
Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018.
Monaldi Arch Chest Dis
; 91(1)2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470083
2.
Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan.
Int J Environ Res Public Health
; 18(11)2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34072161
3.
Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis.
Open Forum Infect Dis
; 8(12): ofab551, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877367
4.
Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015-2017 Cohort from Tashkent, Uzbekistan.
Int J Environ Res Public Health
; 18(11)2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071899